Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Financings in Brief: Sight Resource

This article was originally published in The Gray Sheet

Executive Summary

Sight Resource: Laser vision correction center company, formerly NewVision Technology, nets about $6.1 mil. from the exercise of "more than 99%" of warrants issued in conjunction with a March 1993 initial public offering. The warrants were exercised in conjunction with the Oct. 20 FDA approval of Summit Technology's excimer laser for photorefractive keratectomy ("The Gray Sheet" Oct. 30, p. 4). Sight Resource states that 13 of its lasers are being upgraded for PRK use and it will begin treating patients at its Boston facility on Dec. 15; seven out of 28 Sight Resource centers are expected to be offering PRK by year end...
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT005165

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel